Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1007/S11999-017-5276-Y | ||||
| Año | 2017 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Conclusions This study showed barely fair interobserver and fair to good intraobserver agreement for grading of intramedullary cartilaginous neoplasms by orthopaedic oncologists using initial clinical and imaging findings. These results reflect the insufficient guidance interpreting clinical and imaging features, and the limitations of the systems we use today when making these diagnoses. In the same way, they generate concern for the implications that this may have on different treatment strategies and the future prognosis of our patients. Future studies should build on these observations and focus on clarifying our criteria of diagnosis so that treatment recommendations are standardized regardless of the treating institution or oncologist. Level of Evidence Level III, diagnostic study.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | ZAMORA-HELO, TOMAS | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 2 | URRUTIA-ESCOBAR, JULIO | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 3 | Schweitzer, Daniel | - |
Pontificia Universidad Católica de Chile - Chile
|
| 4 | Pablo Amenabar, Pedro | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 4 | Amenabar Edwards, Pedro Pablo | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| 5 | BOTELLO-CORREA, EDUARDO ANDRES | Hombre |
Pontificia Universidad Católica de Chile - Chile
|
| Fuente |
|---|
| National Cancer Institute |
| Università degli Studi di Padova |
| Federal University of Triângulo Mineiro |
| Camilo Soto MD |
| Instituto Traumatológico de Santiago |
| Pietro Ruggieri MD |
| Eduardo Sadao MD |
| Agradecimiento |
|---|
| We thank the 10 evaluators in this study: Antonio Aguilera MD (Orthopaedic Surgery Service, Hospital Militar Central, Buenos Aires, Argentina); Adriano Jander MD (Orthopaedic Oncology Service, The Federal University of Triângulo Mineiro. Uberaba, Brasil); Camilo Soto MD (Orthopaedic Oncology Service, National Institute of Cancer, Bogotá, Colombia); Eduardo Sadao MD (Orthopaedic Oncology Service, Santa Casa de São Paulo, Brasil); Eduardo Ortiz Cruz MD (Orthopaedic Oncology Department, MD Anderson Cancer Center, Madrid, Spain); Gabriel García-Huidobro MD (Musculoskeletal Oncology Unit, Instituto Traumatológico de Santiago, Chile); Juan Fuenzalida MD (Musculoskeletal Oncology Unit, Hospital Luis Calvo Mackena. Santiago, Chile); Pedro Pericles MD (Orthopaedic Oncology Service, Santa Casa de São Paulo, Brasil); Pietro Ruggieri MD (Orthopaedic Oncology Unit, University of Padua. Padua, Italy); and Roberto Reggiani MD (Orthopedic Surgery Service, Universidade Federal de Uberlândia, Uberlândia, Brasil). Each author certifies that neither he, nor any member of his immediate family, have funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request. Each author certifies that his institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained. |